Empirical treatment with non-anti-tuberculosis antibiotics decreased microbiological detection in cervical tuberculous lymphadenitis

• Published in: Diagnostic microbiology and infectious disease 2018-11, Vol.92 (3), p.245-249
• Main Authors: Dai, Youchao, Wen, Zhihua, Ye, Taosheng, Deng, Guofang, Zhang, Mingxia, Deng, Qunyi, Yang, Qianting, Shan, Wanshui, Kornfeld, Hardy, Cai, Yi, Chen, Xinchun
• Format: Article
• Language: English
• Subjects: Adult; Aged; Anti-Bacterial Agents - pharmacology; Anti-Bacterial Agents - therapeutic use; Bacterial Load; Biopsy, Fine-Needle; Cervical tuberculous lymphadenitis; Empirical treatment; Female; Humans; Lymph node enlargement; Lymph Nodes - microbiology; Lymph Nodes - pathology; Male; Microbiological detection; Middle Aged; Mycobacterium tuberculosis - drug effects; Non-anti-tuberculosis; Retrospective Studies; Treatment Outcome; Tuberculosis, Lymph Node - diagnosis; Tuberculosis, Lymph Node - drug therapy; Tuberculosis, Lymph Node - microbiology; Young Adult
• ISSN: 0732-8893; 1879-0070
• DOI: 10.1016/j.diagmicrobio.2018.06.008

Diagnosis of cervical tuberculous lymphadenitis (CTL), the most commonly occurring form of extrapulmonary tuberculosis, remains as a challenge in clinic. Detection of the presence of Mycobacterium tuberculosis (Mtb) in fine needle aspiration cytology (FNAC) samples is one golden criterion to confirm the CTL diagnosis. Due to the non-specific clinical presentation, CTL might be confused with other lymph node enlargement diseases; therefore empirical treatment with non-anti-TB antibiotics is often initially administered. However, it is still unclear whether this diagnostic antibiotic treatment affects the positivity of Mtb detection in FNAC. The demographics and clinical characteristics of 732 lymph node enlargement patients who had underwent FNAC were retrospectively analyzed and 605 (82.65%) of them were diagnosed as CTL. A total of 279 CTL cases (279/605, 46.11%) with completion of three Mtb tests (AFB, NAAT, and Mtb culture) in FNAC samples were selected for analyzing the effect of empirical antibiotic treatment on the positivity of Mtb tests. Compared to CTL patients without antibiotic treatment prior to FNAC, patients received empirical non anti-TB treatment had significantly lower positivity for acid fast bacilli staining (adjusted OR 0.11, 95% CI 0.06–0.21), nucleic acid amplification test (NAAT) (adjusted OR 0.38, 95% CI 0.21–0.71), and Mtb culture (adjusted OR 0.11, 95% CI 0.06–0.19). In conclusion, this study demonstrated that empirical non anti-TB antibiotic treatment reduced the opportunity to confirm CTL by microbiological analysis. Patients with cervical lymph node enlargement should undergo FNAC for Mtb tests prior to initiation of empirical non anti-TB treatment. •CTL accounted for the most cases of cervical lymph node enlargement.•CTL patients with typical tuberculous cytopathology tended to be found with higher positivity of Mtb in molecular and culture methods.•Empirical non-anti-TB antibiotic treatment reduced the opportunity to confirm CTL by microbiological analysis.